Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Cell Point (India) IPO.
July 19, 2024 12:59:00 PM
Mobile-advertising firm InMobi Pte is planning to go public in India in the second half of next year, seeking to capitalize on a booming stock market in the world�s fifth-largest economy.
Published by : Bloomberg L.P.July 5, 2024 5:00:00 PM
Jio is India�s largest mobile operator and it is growing its customer base, sales and profitsIt has also just hiked up its tariffsAll of this is suggesting to ...
Published by : TelecomTVJuly 19, 2024 12:26:00 PM
Artiva Biotherapeutics has upsized its IPO to $167 million as the allogeneic natural killer (NK) cell therapy prepares to list on the Nasdaq this morning. | The biotech has knocked its share price ...
Published by : FierceBiotechJune 27, 2024 7:31:00 AM
Sign up for the India Edition newsletter by Menaka Doshi � an insider's guide to the emerging economic powerhouse, and the billionaires and businesses behind its ...
Published by : Bloomberg L.P.July 19, 2024 11:39:00 AM
Cell therapy startup Artiva Biotherapeutics will go public on Friday morning in the 11th biotech IPO this year. Its Wall Street debut adds to the industry's modest rebuilding in 2024 following a ...
Published by : ENDPOINTS NEWSJuly 11, 2024 7:31:00 PM
This stance will likely boost the Indian IPO market, fueling growth in capital deployment in the public markets with new companies entering the fray. Corporate India�s performance in the March ...
Published by : ForbesJuly 5, 2024 5:16:22 PM
Reliance Jio Infocomm's recent tariff hikes and 5G monetisation strategies suggest a potential IPO next year, possibly India's largest. Analysts expect clarity at Reliance Industries Ltd's upcoming ...
Published by : Times Now on MSNJuly 18, 2024 11:11:00 PM
The offering comes days after the publication of a paper showing what analysts said was early proof that �off-the-shelf� cell therapies can treat inflammatory diseases.
Published by : BioPharma DiveJune 27, 2024 4:31:00 PM
[NEWS1] The Indian subsidiary of Hyundai Motor aims to complete its initial public offering (IPO) by October, according to the Korean automaker�s chief. Hyundai Motor CEO Chang Jae-hoon ...
Published by : MSNJuly 19, 2024 3:30:00 AM
Artiva Biotherapeutics Inc. raised $167 million through an upsized IPO, with funds aimed at the development of its lead AlloNK program for systemic lupus erythematosus and other autoimmune indications ...
Published by : BioWorldJuly 1, 2024 11:19:00 AM
The biotech does maintain another partnership in the form of Affimed. The two companies agreed in November 2022 to evaluate combining Affimed�s innate cell engager AFM13 with one of Alumis� NK ...
Published by : FierceBiotechJuly 19, 2024 9:13:00 PM
Artiva Biotherapeutics Inc. raised $167 million through an upsized IPO, with funds aimed at the development of its lead AlloNK program for systemic lupus erythematosus and other autoimmune indications ...
Published by : BioWorldThe IPO Shares of Cell Point (India) Limited IPO are proposed to list on Wednesday, June 28, 2023 at NSE SME. The public issue of Cell Point (India) IPO was opened on Jun 15, 2023 and closed for subscription on Jun 20, 2023. Cell Point (India) IPO Listing Date and Information:
| Listing Date | Wednesday, June 28, 2023 |
| BSE Script Code | |
| NSE Symbol | CELLPOINT |
| Listing In | |
| ISIN | INE0O0001013 |
| Issue Price | ₹100 Per Equity Share |
| Face Value | ₹10 Per Equity Share |
The allotment status of Cell Point (India) Limited IPO is now available online. The public issue of Cell Point (India) IPO was open on Jun 15, 2023 and closed for subscription on Jun 20, 2023. The equity shares of the company to be list at NSE SME
.
Cell Point (India) Limited is entering in the capital market with an IPO of 5,034,000 Equity Shares of Rs 10 aggregating up to Rs 50.34 Crore. The price for the issue has been set at Rs 100 Per Equity Share.
Incorporated in 2001, Cell Point (India) Limited is engaged in multi-brand retail selling of Smart Phones, tablets, mobile accessories, and mobile-related products and allied accessories from manufacturers like Apple, Samsung, Oppo, Realme, Nokia, Vivo, Xiaomi, Redmi, and Oneplus.
The issue opens on Jun 15, 2023 and closes for subscription on Jun 20, 2023. The equity shares of the company to be list at NSE SME.
The issue of Cell Point (India) Limited opens on Jun 15, 2023 and closes for subscription on Jun 20, 2023. The equity shares of the company to be list at NSE SME. The price for the issue has been set at Rs 100 Per Equity Share.
The Cell Point (India) IPO is proposed to open on June 15, 2023. The IPO application ends on June 20, 2023.
Retail investors can apply in the retail or non-institutional investor category from June 15, 2023 to June 20, 2023. The Cell Point (India) IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Cell Point (India) IPO will open for subscription on June 15, 2023. The public issue will close on June 20, 2023.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
